MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
4.520
+0.470 (11.60%)
At close: Jul 2, 2026, 4:00 PM EDT
4.500
-0.020 (-0.44%)
After-hours: Jul 2, 2026, 7:51 PM EDT
MannKind Market Cap
MannKind has a market cap or net worth of $1.4 billion as of July 2, 2026. Its market cap has increased by 22.53% in one year.
Market Cap
1.40B
Enterprise Value
1.70B
1-Year Change
22.53%
Ranking
Category
Stock Price
$4.52
Market Cap Chart
Since July 28, 2004, MannKind's market cap has increased from $445.50M to $1.40B, an increase of 213.46%. That is a compound annual growth rate of 5.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 1.40B | -19.79% |
| Dec 31, 2025 | 1.74B | -1.82% |
| Dec 31, 2024 | 1.77B | 80.71% |
| Dec 29, 2023 | 981.30M | -29.25% |
| Dec 30, 2022 | 1.39B | 26.32% |
| Dec 31, 2021 | 1.10B | 50.82% |
| Dec 31, 2020 | 728.00M | 173.38% |
| Dec 31, 2019 | 266.30M | 57.39% |
| Dec 31, 2018 | 169.20M | -37.75% |
| Dec 29, 2017 | 271.80M | -10.74% |
| Dec 30, 2016 | 304.50M | -48.72% |
| Dec 31, 2015 | 593.80M | -71.93% |
| Dec 31, 2014 | 2.12B | 13.87% |
| Dec 31, 2013 | 1.86B | 227.29% |
| Dec 31, 2012 | 567.70M | 72.92% |
| Dec 30, 2011 | 328.30M | -67.35% |
| Dec 31, 2010 | 1.01B | 1.76% |
| Dec 31, 2009 | 988.20M | 183.23% |
| Dec 31, 2008 | 348.90M | -56.57% |
| Dec 31, 2007 | 803.30M | -2.49% |
| Dec 29, 2006 | 823.80M | 45.65% |
| Dec 30, 2005 | 565.60M | 9.46% |
| Dec 31, 2004 | 516.70M | 15.98% |
| Jul 28, 2004 | 445.50M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 1.56B |
| MoonLake Immunotherapeutics | 1.55B |
| Septerna | 1.54B |
| Hemab Therapeutics Holdings | 1.46B |
| Inhibrx Biosciences | 1.38B |
| Immatics | 1.34B |
| Capricor Therapeutics | 1.31B |
| Avalyn Pharma | 1.29B |